ReviewPharmacoEconomics2010

Fondaparinux: a pharmacoeconomic review of its use in the management of non-ST-segment elevation acute coronary syndrome.

Kate McKeage et al.PubMed ↗Publisher ↗

No numbers read from the abstract.